Back

Levosimendan protects against doxorubicin induced acute cardiotoxicity by regulation of oxidative stress and by activation of antiapoptotic mechanisms.

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Heart failure LV dysfunction Cardiotoxicity of drugs ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Panagiotis Efentakis

National & Kapodistrian University of Athens, Athens (Greece)

47 More presentations in this session

Presentation thumbnail
Associate Professor A. Kovacs (Budapest, HU)
Abstract
Presentation thumbnail
Doctor A. Ayesta Lopez (Madrid, ES)
Abstract
Presentation thumbnail
Associate Professor E. Bollano (Gothenburg, SE)
Presentation thumbnail
Doctor C. Zanchin (Bern, CH)
Abstract Slides
Presentation thumbnail
Doctor S. Stampfli (Lucerne, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Heart failure LV dysfunction

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources